{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:54:14Z","timestamp":1789718054964,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"KAKENHI","award":["15K09663"],"award-info":[{"award-number":["15K09663"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12185-017-2213-5","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T07:22:29Z","timestamp":1489648949000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation"],"prefix":"10.1007","volume":"106","author":[{"given":"Takashi","family":"Ishihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitaka","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"key":"2213_CR1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","volume":"120","author":"CH Pui","year":"2012","unstructured":"Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120:1165\u201374.","journal-title":"Blood"},{"key":"2213_CR2","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2007-04-084293","volume":"111","author":"BJ Lange","year":"2008","unstructured":"Lange BJ, Smith FO, Feusner J, Barnard DR, Dinndorf P, Feig S, et al. Outcomes in CCG-2961, a children\u2019s oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children\u2019s oncology group. Blood. 2008;111:1044\u201353.","journal-title":"Blood"},{"key":"2213_CR3","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1200\/JCO.2006.06.5037","volume":"24","author":"U Creutzig","year":"2006","unstructured":"Creutzig U, Zimmermann M, Lehrnbecher T, Graf N, Hermann J, Niemeyer CM, et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol. 2006;24:4499\u2013506.","journal-title":"J Clin Oncol"},{"key":"2213_CR4","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1200\/JCO.2008.18.7948","volume":"27","author":"I Tsukimoto","year":"2009","unstructured":"Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, et al. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. J Clin Oncol. 2009;27:4007\u201313.","journal-title":"J Clin Oncol"},{"key":"2213_CR5","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/sj.leu.2403924","volume":"19","author":"BE Gibson","year":"2005","unstructured":"Gibson BE, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK, et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia. 2005;19:2130\u20138.","journal-title":"Leukemia"},{"key":"2213_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116\u201322.","journal-title":"Hepatology"},{"key":"2213_CR7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778\u201383.","journal-title":"Transplantation"},{"key":"2213_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0268-960X(93)90023-W","volume":"7","author":"E Carreras","year":"1993","unstructured":"Carreras E, Gra\u00f1ena A, Rozman C. Hepatic veno-occlusive disease after bone marrow transplant. Blood Rev. 1993;7:43\u201351.","journal-title":"Blood Rev"},{"key":"2213_CR9","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood. 1995;85:3005\u201320.","journal-title":"Blood"},{"key":"2213_CR10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","volume":"40","author":"ED Batts","year":"2007","unstructured":"Batts ED, Lazarus HM. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant. 2007;40:709\u201319.","journal-title":"Bone Marrow Transplant"},{"key":"2213_CR11","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118:1452\u201362.","journal-title":"Blood"},{"key":"2213_CR12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:571\u20135.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2213_CR13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","volume":"92","author":"T Ruutu","year":"2007","unstructured":"Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007;92:95\u2013100.","journal-title":"Haematologica"},{"key":"2213_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/1024533031000084231","volume":"8","author":"M Kaleelrahman","year":"2003","unstructured":"Kaleelrahman M, Eaton JD, Leeming D, Bowyer K, Taberner D, Chang J, et al. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF). Hematology. 2003;8:91\u20135.","journal-title":"Hematology"},{"key":"2213_CR15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1160\/TH04-09-0621","volume":"93","author":"MT Sartori","year":"2005","unstructured":"Sartori MT, Spiezia L, Cesaro S, Messina C, Paris M, Pillon M, et al. Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population. Thromb Haemost. 2005;93:682\u20139.","journal-title":"Thromb Haemost"},{"key":"2213_CR16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-3046.2006.00612.x","volume":"11","author":"SW Eber","year":"2007","unstructured":"Eber SW, Gungor T, Veldman A, Sykora K, Scherer F, Fischer D, et al. Favorable response of pediatric stem cell recipients to human protein C concentrate substitution for veno-occlusive disease. Pediatr Transplant. 2007;11:49\u201357.","journal-title":"Pediatr Transplant"},{"key":"2213_CR17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/bmt.2009.227","volume":"45","author":"A Pinom\u00e4ki","year":"2010","unstructured":"Pinom\u00e4ki A, Volin L, Joutsi-Korhonen L, Virtanen JO, Lemponen M, Ruutu T, et al. Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHD. Bone Marrow Transplant. 2010;45:730\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"2213_CR18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1160\/TH13-04-0345","volume":"110","author":"T Matsumoto","year":"2013","unstructured":"Matsumoto T, Nogami K, Shima M. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis. Thromb Haemost. 2013;110:761\u20138.","journal-title":"Thromb Haemost"},{"key":"2213_CR19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2052-0492-2-20","volume":"2","author":"H Asakura","year":"2014","unstructured":"Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care. 2014;2:20.","journal-title":"J Intensive Care"},{"key":"2213_CR20","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/ATVBAHA.112.251157","volume":"32","author":"T Ikezoe","year":"2012","unstructured":"Ikezoe T, Yang J, Nishioka C, Honda G, Furihata M, Yokoyama A. Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase\/myeloid leukemia cell-1 signaling. Arterioscler Thromb Vasc Biol. 2012;32:2259\u201370.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2213_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/bmt.2016.195","volume":"52","author":"T Ikezoe","year":"2017","unstructured":"Ikezoe T, Yang J, Nishioka C, Pan B, Xu K, Furihata M, et al. The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine model. Bone Marrow Transplant. 2017;52:73\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"2213_CR22","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1161\/01.ATV.0000244680.14653.9a","volume":"26","author":"LO Mosnier","year":"2006","unstructured":"Mosnier LO, Bouma BN. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis. Arterioscler Thromb Vasc Biol. 2006;26:2445\u201353.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2213_CR23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/trf.13437","volume":"56","author":"H Fujiwara","year":"2016","unstructured":"Fujiwara H, Maeda Y, Sando Y, Nakamura M, Tani K, Ishikawa T, et al. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin. Transfusion. 2016;56:886\u201392.","journal-title":"Transfusion"},{"key":"2213_CR24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1160\/TH10-12-0802","volume":"105","author":"S Nomura","year":"2011","unstructured":"Nomura S, Ozasa R, Nakanishi T, Fujita S, Miyaji M, Mori S, et al. Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation? Thromb Haemost. 2011;105:1118\u201320.","journal-title":"Thromb Haemost"},{"key":"2213_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JBM.S93008","volume":"7","author":"S Nomura","year":"2016","unstructured":"Nomura S, Maeda Y, Ishii K, Katayama Y, Yagi H, Fujishima N, et al. Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation. J Blood Med. 2016;7:1\u20134.","journal-title":"J Blood Med."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-017-2213-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2213-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2213-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T20:00:32Z","timestamp":1601755232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-017-2213-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2213"],"URL":"https:\/\/doi.org\/10.1007\/s12185-017-2213-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}